Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jan 27, 2024; 16(1): 103-112
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.103
Table 1 Patient characteristics
Variable

Total (n = 100)
Control (n = 47)
UDCA (n = 53)
Age (yr), median (P25, P75)53.00 (48, 60)51 (47, 60)54 (48.5, 60)
Gender, n (%)Male44 (44)21 (44.68)23 (23.40)
Female56 (56)26 (55.32)30 (56.60)
Jaundice, n (%)Yes27 (27)12 (25.53)15 (28.30)
No73 (73)35 (74.47)38 (71.70)
Hypertension, n (%)Yes25 (25)12 (25.53)14 (26.42)
No75 (75)35 (74.47)39 (73.58)
Diabetes, n (%)Yes32 (32)14 (29.79)18 (33.96)
No68 (68)33 (70.21)35 (66.04)
History of biliary tract surgery, n (%)Yes14 (14)6 (12.77)8 (15.09)
No86 (86)41 (87.23)45 (84.91)
Parapillary diverticulum, n (%)Yes36 (36)23 (48.94)13 (24.53)
No64 (64)24 (51.06)40 (75.47)
No. of stones, n (%)≤ 349 (49)25 (53.19)24 (45.28)
> 351 (51)22 (46.81)29 (54.72)
Bile culture positive, n (%)37 (37)20 (42.55)17 (32.08)
Common bile duct diameter (mm), median (P25, P75)14.00 (13.00, 16.00)15.0 (13.0, 16.0)14.0 (12.0, 16.0)
Maximum stone diameter (mm), median (P25, P75)13.00 (12.00, 15.00)13.0 (12.0, 15.0)13.0 (11.5, 14.5)
ERCP time (min), median (P25, P75)64.00 (61.00, 68.00)63 (61, 67)64 (61, 71)
WBC (109/L, mean ± SD)6.60 ± 0.966.24 ± 1.246.60 ± 0.97
PCT (ng/mL), median (P25, P75)0.18 (0.12, 0.27)0.17 (0.12, 0.25)0.18 (0.13, 0.28)